lesspain.ai

100+

Patient Sessions Delivered

80%

Maximum Reduction in Pain

EU MDR

Compliant with Class I

ABOUT THE PROJECT

The Challenge

Chronic pain impacts 20% of the global population, diminishing quality of life and creating reliance on risky, habit-forming medications. MORPHEUS is an AI-driven VR platform delivering personalized, drug-free pain relief through immersive distraction and long-term neuro-conditioning.
How It Works: The MORPHEUS protocol is a seamless, closed-loop cycle for both clinical and home settings:

1. Detection: The cycle begins during a pain flare-up or before a procedure.
2. Immerse: Equip a commodity VR headset and paired medical smartwatch.
3. Active Therapy: Engage in a 4-minute AI-adapted simulation while Heart Rate Variability (HRV) is monitored in real-time.
4. Instant Relief: Experience immediate pain reduction of up to 80% via immersive distraction.
5. Conditioning: The system pairs relief with specific haptic and auditory triggers.
6. Persistence: Post-session, the smartwatch uses these triggers to reduce pain by 36% without the headset.

We target hospital pain departments, private physiotherapy clinics, and health insurers seeking cost-effective digital therapeutics. The MORPHEUS system is fully proprietary and protected under the "Virtual-Reality Pain-Management and Neuro-Conditioning System" patent.

Project Demos

Experience the Morpheus Platform in Action

Patient Experience

Level Showcase

The Product

Applying Artificial Intelligence for Distraction Therapy and Affective Conditioning.

Hardware

Designed to work on commercial XR headsets and mobile devises, developed to work with existing infrastructure and consumer grade technology. Limited space is required, can be easily used sitting or laying down.

Software

Our custom application offers direct installation on your hardware with a fritionless set up process. Once installed runs without the need for staff oversights, patients get their own profiles.

AI & ML

Integrated onboard Artificial Intelligence that adjusts the experience in real-time for each patient. Personalised experiences optimised for maximum distraction and minimal pain.

Security

On-Device Artificial Intelligence combined with local data processing ensures all infomration is kept private for user saftey. Additionally complete anonimisation of user profiles and model weights enables safe continious updates.

Results & Milestones

Validation, Certification, and Growth

Peer-Reviewed Validation

Methodology published in Springer Nature (Vol. 463) and IEEE Xplore (Vol. 2025), confirming superiority over standard care.

Clinical Efficacy

Achieved 80% immediate pain reduction during sessions and 36% sustained relief for up to 120 minutes post-therapy.

International Recognition

Awarded "Best New Paper" at AIVR 2025 (Osaka) for revolutionizing pain management via AI-driven conditioning.

Regulatory Approval

Compliant with EU MDR specifications for Software as a Medical Device (SaMD) under Class I category, designed for hospital and home deployment.

Application for Patent

Intellectual Propert Application filing to protect our unique and proprietary Artificial Intelligence powered adaptive pain reduction and conditioning.

Traction & Readiness

Validated by 100+ patient trials with five finalized high-fidelity VR environments ready for consumer use.

Market Scalability

Hardware entry cost reduced to <€300 using commodity tech, ensuring accessible and scalable global deployment.

Market Comparison

Contrasting Morpheus with standard care and alternative digital therapies.

Feature	Standard Care (Pharmacological)	Generic Digital Therapy (VR)	MORPHEUS AI Platform
Pain Reduction	High initial relief, but diminishing returns due to tolerance	Typically limited to ~50% during the session	Up to 80% reduction through optimized distraction
Duration of Effect	Temporary; requires frequent dosing	Relief ceases immediately upon headset removal	Persistent Analgesia (Up to 120 mins post-session)
Personalization	One-size-fits-all dosing models	Static, "open-loop" content with no real-time adjustment	Closed-loop AI adapts to emotional state (affective computing)
Deployment Effort	High clinical burden for monitoring addiction/side effects	Often requires high-end, proprietary hardware (~$2,500+)	Commodity Hardware (Low cost < €300 entry)
User Safety	Risks of addiction, tolerance, and organ damage	Minimal; potential for minor motion sickness	Safe & Non-Invasive; no chemical dependency risks

Our Team

The team behind the project.

Contact Us

Speak to the founders

Our Address

University of Malta, Msida, MSD 2080, Malta

Email Us

morpheus@um.edu.mt

Call Us

+356 2340 3567 / +356 79424536

MORPHEUS.

Clinically validated XR therapy reducing pain and anxiety in hospital procedures

AI Enable Distraction Therapy and Affective Conditioning